![Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics](https://pubs.rsna.org/cms/10.1148/rg.2021210005/asset/images/medium/rg.2021210005.tbl1.png)
Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics
Performance of preoperative plasma tumor markers HE4 and CA125 in predicting ovarian cancer mortality in women with epithelial ovarian cancer | PLOS ONE
![Risk of ovarian cancer in women with symptoms in primary care: population based case-control study | The BMJ Risk of ovarian cancer in women with symptoms in primary care: population based case-control study | The BMJ](https://www.bmj.com/content/bmj/339/bmj.b2998/F2.large.jpg)
Risk of ovarian cancer in women with symptoms in primary care: population based case-control study | The BMJ
![Diagnostic value of serum tumor markers for epithelial ovarian cancer stage I-II -- A retrospective analysis - Authorea Diagnostic value of serum tumor markers for epithelial ovarian cancer stage I-II -- A retrospective analysis - Authorea](https://authorea.com/users/470518/articles/562613-diagnostic-value-of-serum-tumor-markers-for-epithelial-ovarian-cancer-stage-i-ii-a-retrospective-analysis/master/file/figures/image1/image1.png?1648648638)
Diagnostic value of serum tumor markers for epithelial ovarian cancer stage I-II -- A retrospective analysis - Authorea
![Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics](https://pubs.rsna.org/cms/10.1148/rg.2021210005/asset/images/medium/rg.2021210005.va.gif)
Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics
![Blood ovarian cancer marker test. CA 125. Uterus, ovary with a tumor. Vector medical illustration. White background. Stock Vector | Adobe Stock Blood ovarian cancer marker test. CA 125. Uterus, ovary with a tumor. Vector medical illustration. White background. Stock Vector | Adobe Stock](https://as2.ftcdn.net/v2/jpg/02/57/87/91/1000_F_257879110_YXeX5zXJVj9dHFHjP6uDWg7AJPUrKkkj.jpg)
Blood ovarian cancer marker test. CA 125. Uterus, ovary with a tumor. Vector medical illustration. White background. Stock Vector | Adobe Stock
![Senescence induction dictates response to chemo- and immunotherapy in preclinical models of ovarian cancer | PNAS Senescence induction dictates response to chemo- and immunotherapy in preclinical models of ovarian cancer | PNAS](https://www.pnas.org/cms/10.1073/pnas.2117754119/asset/3cf33f51-17dd-4b14-a8b5-a780e466d547/assets/images/large/pnas.2117754119fig01.jpg)
Senescence induction dictates response to chemo- and immunotherapy in preclinical models of ovarian cancer | PNAS
![Review of Ovarian Tumors in Children and Adolescents: Radiologic-Pathologic Correlation | RadioGraphics Review of Ovarian Tumors in Children and Adolescents: Radiologic-Pathologic Correlation | RadioGraphics](https://pubs.rsna.org/cms/10.1148/rg.347130144/asset/images/medium/rg.347130144.tbl2.gif)
Review of Ovarian Tumors in Children and Adolescents: Radiologic-Pathologic Correlation | RadioGraphics
![The untapped potential of ascites in ovarian cancer research and treatment | British Journal of Cancer The untapped potential of ascites in ovarian cancer research and treatment | British Journal of Cancer](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41416-020-0875-x/MediaObjects/41416_2020_875_Fig1_HTML.png)